Free Trial

Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average - Should You Sell?

Northwest Biotherapeutics logo with Medical background

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.39 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.29, with a volume of 1,782,919 shares.

Northwest Biotherapeutics Trading Up 4.8 %

The business's 50-day simple moving average is $0.31 and its 200-day simple moving average is $0.39. The company has a market capitalization of $361.14 million, a PE ratio of -4.19 and a beta of -0.58.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last announced its quarterly earnings results on Friday, August 9th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $0.51 million for the quarter.

About Northwest Biotherapeutics

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Recommended Stories

→ 625,000% Gain (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in Northwest Biotherapeutics right now?

Before you consider Northwest Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.

While Northwest Biotherapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!
How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines